Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

R.P. Scherer sells ophthalmic delivery system to Pharmacia & Upjohn

Aug. 26, 1997

Molecular Dynamics and Amersham announce microarray technology agreement with Chiron

Aug. 26, 1997

Alexion reports novel retroviral vectors for gene therapy

Aug. 22, 1997

Gene interaction studies without blood tests

Aug. 22, 1997

ISO 9001 given to Senetek for drug delivery system

Aug. 22, 1997

Millennium reports discovery of new MAD-related proteins

Aug. 21, 1997

Oxis granted patent application allowance for ergothioneine analogs

Aug. 20, 1997

Three patents issued for ProLease and Medisorb

Aug. 19, 1997

Drug discovery agreement forged by Procept, Abbott

Aug. 18, 1997

Onyx, W-L collaborate on antiinflammatory and immunomodulating agents

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...